Affinity Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Affinity Biosciences's estimated annual revenue is currently $1.4M per year.
- Affinity Biosciences's estimated revenue per employee is $155,000
Employee Data
- Affinity Biosciences has 9 Employees.
- Affinity Biosciences grew their employee count by 0% last year.
Affinity Biosciences's People
| Name | Title | Email/Phone |
|---|
Affinity Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $1.7M | 11 | 0% | N/A | N/A |
#3 | $0.8M | 5 | 0% | N/A | N/A |
#4 | $5.1M | 33 | 14% | N/A | N/A |
#5 | $64.6M | 417 | 2% | N/A | N/A |
#6 | $1.7M | 11 | -8% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $7.4M | 48 | -41% | N/A | N/A |
#9 | $0.6M | 4 | 0% | N/A | N/A |
#10 | $0.9M | 12 | 20% | N/A | N/A |
What Is Affinity Biosciences?
Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development. Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Affinity Biosciences News
Spruce Biosciences: Libbie Mansell was named chief regulatory and quality ... of affinity reagent development at Seattle-based Nautilus.
The posters highlight the use of the Company's proprietary IMTAC (Isobaric Mass-Tagged Affinity Characterization) platform in small...
TAB009/JS009 binds specifically to CD112R with high affinity and effectively blocks the interaction between CD112R and its ligand CD112, thereby...
Other Companies in Cincinnati
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 9 | N/A | N/A |
#2 | $1.2M | 9 | 13% | N/A |
#3 | $0.7M | 9 | 0% | N/A |
#4 | $0.7M | 9 | 0% | N/A |
#5 | $0.7M | 9 | 0% | N/A |